Macromolecules Flashcards
what are the types of RNA therapeutics?
Antisense oligonucleotides (ASO’s): inhibit mRNA translation.
RNA interference (RNAi): RNA inhibitors of gene expression by degradation of mRNA.
Forms a RNA –induced silencing complex with a protein ( Argonaute)
Ribozymes: catalytically active RNAs. Cleave covalent bonds in a target RNA.
Aptamers: protein-binding RNAs. Length of RNA that binds to a protein (like a small molecule inhibitor)
RNA vaccines: introduces mRNA sequence coded for a disease specific antigen into cells to build up an immune response
what are Antisense Oligonucleotides (ASOs)?
short strand
Entry of this RNA into the cell can lead to target protein knockdown in the cytoplasm or the nucleus:
what happens when ASOs bind in the cytoplasm?
bind to mRNA
– triggers ribonuclease (RNase H) activity OR
– inhibits ribosomal mRNA translation by steric hindrance.
what happens when ASOs bind in the nucleus?
regulates mRNA maturation
how do ASOs regulate mRNA maturation?
– inhibition of 5’ cap being formed OR
– inhibition of RNA splicing OR
– recruits ribonuclease (RNase H)
what are some examples of RNA interference?
siRNA
RNAi
whats the difference between ASO’s and RNAi?
what are RNA interferences?
how do ribozymes work?
cleave mRNA molecules next to a recognition sequence = destroying RNA sequences
similar to protein nucleases
how do aptamers work?
aptamer sequence = functional aptamer = target binding = preventing functionality of bound molecule
half life of RNA
short half life = fast degradation
when may RNA vaccines not be safe to administer?
for patients susceptible to autoimmune response
LOOK AT NOTES FOR DESIGNING OLIGONUCLEOTIDES
what is the disadvantage of RNA therapeutics?
- enzyme degradation - activity of ribonuclease
- fast excretion - unmodified oligonucleotides have a poor PK due to weak plasma binding = filtration thru the kidney
- poor absorption/bioavailability= poor cellular uptake
what can chemical modifications do to oligonucleotides?
stabilise ASOs and resistant to ribonucleases = increase half life
retain/improve RNAse H efficacy
reduce immunogenicity
increase affinity and potency
decrease non-sequence specific toxicity